Drawing for E-PATH

USPTO serial 99181064

E-PATH

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
COOK, RYAN ARMON
Law office
TMO LAW OFFICE 135

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with E-PATH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kelly R Vehec

Kelly R. Vehec Babst Calland Clements and Zomnir, P.C.603 Stanwix StreetTwo Gateway Center, 9th FloorPittsburgh, PA 15222

Goods and services

ClassDescriptionStatusFirst use
009Downloadable cloud-based software for reporting and extracting pathology data for healthcare providers, life sciences organizations and research institutionsACTIVEMar 1, 2025
042Software as a service (SAAS) services featuring software using artificial intelligence (AI) for automating, analyzing, identifying and reporting in the fields of cancer diagnosis, pathology, and clinical research; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for automating and standardizing pathology report extraction, analysis, and interpretation; (AI) for automating and standardizing pathology report extraction, analysis, and interpretation; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for automating, analyzing and reporting to enhance clinical workflows in oncology and pathology; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for providing temporary use of non-downloadable software for enhancing clinical workflows in oncology and pathology; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for managing and interpreting pathology data and integrating it with healthcare systems; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for software development and maintenance of software used in the fields of cancer diagnostics and pathology services; Providing medical research information in the field of cancer diagnostics and pathology for medical research purposes; Technical consultancy in the field of the using pathology software in clinical workflows in the field of the medical diagnosis of cancerACTIVEJan 1, 2019
044Medical analysis services for the diagnosis of cancer; Providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns; Providing medical information in the field of cancer diagnostics and pathology, not for medical research purposes; Medical analysis services relating to the treatment of patients; Providing medical information, consultancy and advisory services; Consultancy in the field of the medical diagnosis of cancer for treatment or diagnostic purposes for patients using pathology software in clinical workflows, for treatment or diagnostic purposes for patients and not for medical research purposes; Medical diagnostic testing, monitoring and reporting servicesACTIVEJan 1, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Oct 14, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 14, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 2, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 1, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 1, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 1, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 24, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jun 24, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Mar 30, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Dec 12, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 12, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 12, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 6, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 6, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 6, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 4, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 4, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 4, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 25, 2025DOCKASSIGNED TO EXAMINER—
Sep 21, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 12, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
May 12, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance